{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:49:45Z","timestamp":1795024185277,"version":"4.10.2"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pseudohypoparathyroidism is a rare genetic disease characterized by hypocalcaemia and hyperphosphataemia due to the defect to the guanine nucleotide-binding protein alpha subunit (GNAS) gene. Patients with pseudoparathyroidism type 1a and 1c could manifest Albright\u2019s hereditary osteodystrophy and multiple hormone resistance including gonadotropin and thyroid stimulating hormone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>Here we report a Chinese man who presented with fatigue, recurrent seizure and Albright\u2019s hereditary osteodystrophy. His genetic study revealed a heterozygote mutation in the<jats:italic>GNAS<\/jats:italic>gene [NM_000516.4(<jats:italic>GNAS<\/jats:italic>): c2787_2788del (p.Val930AspfsTer12)]. After calcium and calcitriol supplement, his seizures achieved partially remission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We report a case of PHP1a or 1c with a novel frameshift mutation in<jats:italic>GNAS<\/jats:italic>gene in a patient presenting with AHO, as well as TSH and partial gonadotropin resistance. This mutation in this case has not been reported in literature and adds to the spectrum of genetic mutations related to PHP.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12902-020-00651-z","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T07:21:01Z","timestamp":1610176861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A novel GNAS mutation in pseudohypoparathyroidism type 1a in a Chinese man presented with recurrent seizure: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Difei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"651_CR1","first-page":"922","volume":"30","author":"F Albright","year":"1942","unstructured":"Albright F, Burnett CH, Smith PH, Parson W. Pseudohypoparathyroidism ---- an example of \u2018Seabright \u2013bantam syndrome. Endocrinology. 1942;30:922\u201332.","journal-title":"Endocrinology."},{"issue":"6","key":"651_CR2","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1210\/jc.2015-3909","volume":"101","author":"DM Shoback","year":"2016","unstructured":"Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA, Peacock M, Raffaelli M, Silva BC, Thakker RV, Vokes T, Bouillon R. Presentation of hypoparathyroidism: etiologies and clinical features. J Clin Endocrinol Metab. 2016;101(6):2300\u201312.","journal-title":"J Clin Endocrinol Metab"},{"key":"651_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.12809\/hkmj134025","volume":"20","author":"V Tam","year":"2014","unstructured":"Tam V, Chen S, Mak C, Fung LM, Lee CY, Chan A. A novel mutation in pseudohypoparathyroidism type 1a in a Chinese woman and her son with hypocalcaemia. Hong Kong Med J. 2014;20:258\u201360.","journal-title":"Hong Kong Med J"},{"key":"651_CR4","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.4158\/EP14020.CR","volume":"20","author":"SK Chaubey","year":"2014","unstructured":"Chaubey SK, Sangla KS. A sporadic case of pseudohypoparathyroidism type 1 and idiopathic primary adrenal insufficiency associated with a novel mutation in the GNAS1 gene. Endocr Pract. 2014;20:e202\u20136.","journal-title":"Endocr Pract"},{"issue":"2","key":"651_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13516","volume":"88","author":"X Chu","year":"2018","unstructured":"Chu X, Zhu Y, Wang O, Nie M, Quan T, Xue Y, Wang W, Jiang Y, Li M, Xia W, Xing X. Clinical and genetic characteristics of pseudohypoparathyroidism in the Chinese population. Clin Endocrinol. 2018;88(2):285\u201391.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"651_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2265.2007.03025.x","volume":"68","author":"M Mouallem","year":"2008","unstructured":"Mouallem M, Shaharabany M, Weintrob N, Shalitin S, Nagelberg N, Shapira H, Zadik Z, Farfel Z. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha. Clin Endocrinol. 2008;68(2):233\u20139.","journal-title":"Clin Endocrinol"},{"key":"651_CR7","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/ajmg.a.32346","volume":"A 146A","author":"NS Adegbite","year":"2008","unstructured":"Adegbite NS, Xu M, Kaplan FS, Shore EM, Pignolo RJ. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS \u2013based heterotopic ossification. Am J Med Genet. 2008;A 146A:1788\u201396.","journal-title":"Am J Med Genet"},{"key":"651_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.sc.3101761","volume":"43","author":"P Schuetz","year":"2005","unstructured":"Schuetz P, Mueller B, Christ-Crain M, Dick W, Haas H. Amino-biphosphonates in heterotopic ossification: first experience in five consecutive cases. Spinal Cord. 2005;43:604\u201310.","journal-title":"Spinal Cord"},{"key":"651_CR9","first-page":"824","volume":"83","author":"AB Namnoum","year":"1998","unstructured":"Namnoum AB, Merriam GR, Moses AM, Levine MA. Reproductive dysfunction in woman with Albright\u2019s hereditary osteodystrophy. J Clin Endocrinol Metab. 1998;83:824\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"651_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","volume":"14","author":"G Mantovani","year":"2018","unstructured":"Mantovani G, Bastepe M, Monk D, et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement. Nat Rev Endocrinol. 2018;14(8):476\u2013500.","journal-title":"Nat Rev Endocrinol"},{"key":"651_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1210\/jc.2006-1497","volume":"92","author":"DN Long","year":"2007","unstructured":"Long DN, McGuire S, Levine M, Weinstein LS, Germain-Lee EL. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab. 2007;92:1073\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"651_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/0002-9343(83)91008-2","volume":"74","author":"MA Levine","year":"1983","unstructured":"Levine MA, Downs RW Jr, Moses AM, et al. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med. 1983;74(4):545\u201356.","journal-title":"Am J Med"},{"key":"651_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1530\/acta.0.0930043","volume":"93","author":"G Wagar","year":"1980","unstructured":"Wagar G, Lehtivuori J, Salven I, Backman R, Sivula A. Pseudohypoparathyroidism associated with hypercalcitoninaemia. Acta Endocrinol. (Copenh). 1980;93:43\u20138.","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"651_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/humu.22696","volume":"36","author":"MC Lemos","year":"2015","unstructured":"Lemos MC, Thakker RV. GNAS mutations in pseudohypoparathyroidism type 1a and related disorders. Hum Mutat. 2015;36:11\u20139.","journal-title":"Hum Mutat"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00651-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-020-00651-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00651-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T07:34:25Z","timestamp":1697528065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-020-00651-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1186\/s12902-020-00651-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"8 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for the study was approved by the ethics committee of Peking University First Hospital in accordance with Helsinki Declaration. The patient had given a written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed on the publication of this case report, and written consent to publish was attained from all authors. Also, the patient had given a written informed consent for the publication of his personal or clinical details along with the images to be published in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Difei Lu, Aimei Dong, Junqing Zhang and Xiaohui Guo declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}